Literature DB >> 17470477

Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

Masato Yoneda, M Yoneda, Masashi Yoneda, Koji Fujita, K Fujita, Masahiko Inamori, M Inamori, Masaya Tamano, M Tamano, Hideyuki Hiriishi, H Hiraishi, Atsushi Nakajima, A Nakajima.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17470477      PMCID： PMC1954961          DOI： 10.1136/gut.2007.126417

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.

Authors:  R Moreno-Otero; M Trapero-Marugan; J Mendoza
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 3.  Nonalcoholic steatohepatitis: definition and pathology.

Authors:  E M Brunt
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

4.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998
  4 in total
  69 in total

1.  Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis.

Authors:  Akihiko Osaki; Tomoyuki Kubota; Takeshi Suda; Masato Igarashi; Keisuke Nagasaki; Atsunori Tsuchiya; Masahiko Yano; Yasushi Tamura; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Toru Kikuchi; Minoru Nomoto; Yutaka Aoyagi
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

Review 2.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.

Authors:  Wah-Kheong Chan; Nik Raihan Nik Mustapha; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Sanjiv Mahadeva
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

4.  Transient elastography in chronic hepatitis B: an Asian perspective.

Authors:  Seung Up Kim; Kwang-Hyub Han; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 5.  Recent advances in the pathogenesis and diagnosis of liver fibrosis.

Authors:  Natalie J Török
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

6.  Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.

Authors:  Noriyuki Obara; Yoshiyuki Ueno; Koji Fukushima; Yu Nakagome; Eiji Kakazu; Osamu Kimura; Yuta Wakui; Osamu Kido; Masashi Ninomiya; Takayuki Kogure; Jun Inoue; Yasuteru Kondo; Masaaki Shiina; Takao Iwasaki; Takeshi Yamamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

Review 7.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

8.  A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.

Authors:  Wah-Kheong Chan; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  Hepatol Int       Date:  2014-12-06       Impact factor: 6.047

Review 9.  Clinical approaches to non-alcoholic fatty liver disease.

Authors:  Katherine J P Schwenger; Johane P Allard
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 10.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.